Intravenous products: News Medical report on both sides of a needlefree patent infringement court ruling. ICU medical report on news-medical.net “ICU Medical, Inc., (Nasdaq:ICUI), a leadingÂ manufacturer of safe medical connectors, custom medical products and critical care devices, recently secured a victory in a patent infringement case against RyMed Technologies, Inc.
On December 17, 2010, an eight-person jury in the U.S. District Court of Delaware found that RyMed’s InVision Plus I.V. connector infringes two patents owned by ICU Medical and related to the CLAVE portfolio of products. The jury also confirmed that ICU Medical’s patents are valid.”
In addition, news-medical.net also report “Dana Wm. Ryan, President, CEO and Chairman of the Board of RyMed Technologies, Inc., today responded to a mixed verdict in a patent infringement case concerning RyMed’s InVision-Plus® with Neutral Advantage technology IV connector.
While we are disappointed in the jury’s decision on two of the three patents, the entire matter is not yet resolved
On December 17, 2010, an eight-person jury in the U.S. District Court of Delaware determined that there was no willful infringement of any patent. Addtionally, the jury found in RyMed’s favor on one patent but decided against RyMed on two other patents. All three patents are owned by ICU Medical, Inc., which like RyMed makes IV connectors.”